.svg)
If a parent, sibling, or other close relative has had lung cancer, it is natural to wonder whether the same diagnosis could be passed down through your family. The short answer is: lung cancer can cluster in families, but it is not usually hereditary in the same clear-cut way as some breast, ovarian, or colorectal cancers.
Most lung cancers are linked to exposures that build up over time, especially smoking. Still, family history can be an important factor in understanding your risk, particularly when lung cancer appears at a young age or alongside a broader pattern of cancers that may suggest an inherited cancer syndrome.
This article explains what “hereditary” means in the context of lung cancer, which family patterns merit a closer look, and when a conversation with a physician or genetic counselor may be helpful.
Lung cancer itself is not passed directly from parent to child. But a person can inherit genetic changes that may influence cancer susceptibility. In some families, those inherited changes, shared exposures, or both may contribute to more than one lung cancer diagnosis.
That distinction matters:
According to the American Cancer Society, inherited gene changes do not appear to cause very many lung cancers. Smoking remains the leading risk factor; the CDC estimates that cigarette smoking causes about 80% to 90% of lung cancer deaths in the United States.
Yes—sometimes. Having a close relative with lung cancer may be a reason to look more closely at family history, especially if there are patterns that do not fit a typical exposure-related explanation.
Family members can share more than DNA. They may also share smoking exposure, secondhand smoke exposure, radon in the home, or workplace and environmental exposures. That is why a family history alone cannot tell you whether a hereditary gene change is involved.
A genetic counselor or qualified clinician can help sort through those possibilities by looking at the complete family pattern, not just one diagnosis.
There are no widely used hereditary testing criteria based on lung cancer family history alone. However, certain patterns may warrant a broader review of personal and family cancer history, particularly when other cancers associated with hereditary cancer syndromes are also present:
These patterns do not prove that a hereditary syndrome is present. They do give a clinician useful context for deciding whether genetic counseling or testing may be appropriate.
Family history is information. Hereditary cancer syndrome is a medically defined condition caused by an inherited gene change.
For example, some rare inherited conditions can raise the risk of several cancer types. Li-Fraumeni syndrome, which involves harmful changes in the TP53 gene, is one example. It is associated with a broad spectrum of cancers and is typically considered when a family has multiple early-onset cancers, such as breast cancer, sarcoma, brain tumors, or adrenal cancers.
Lung cancer is rarely evaluated in isolation. The broader pattern—cancer types, ages at diagnosis, which side of the family is affected, and smoking history—can provide important context when evaluating risk.
Not in the same way that a BRCA test can clarify certain breast and ovarian cancer risks. There is no single, routine genetic test that can predict who will develop lung cancer.
When hereditary testing is appropriate, it is generally based on the person's broader personal and family cancer history rather than lung cancer risk alone. A hereditary cancer panel looks for inherited changes in genes associated with established cancer syndromes. A result may help guide discussions about screening, risk management, and whether other relatives may want to consider testing.
A negative result does not eliminate lung cancer risk. It simply means the test did not identify one of the inherited changes it was designed to detect. Risk from smoking, radon, and other exposures still matters.
People often hear “genetic testing” after a lung cancer diagnosis, but there are two different kinds of testing with different purposes.
Hereditary cancer-risk testing examines DNA you were born with, usually from blood, saliva, or a cheek swab. It may be considered when personal or family history suggests an inherited cancer syndrome.
Tumor genomic testing examines DNA changes inside an existing tumor. After a lung cancer diagnosis, it can help an oncology team understand tumor biology and inform treatment discussions.
If you or a loved one has been diagnosed with lung cancer, tumor genomic testing may be an important part of the care conversation. Read more in Kadance’s guide to Genetic Testing and Lung Cancer
Genetic counseling can be useful when you are unsure how to interpret family history. A genetic counselor can review:
If testing is recommended, it is often most informative to begin with a relative who has had cancer, when that is possible. Their results may make it easier to understand what other family members should consider.
Family history is one part of your overall lung cancer risk. If lung cancer has occurred in your family, a few steps can help you and your healthcare team better understand the broader picture.
Talk with a physician about your overall risk and screening eligibility. Under current U.S. Preventative Services Task Force (USPSTF) recommendations, annual low-dose CT screening is recommended for certain adults ages 50 to 80 based primarily on smoking history and other eligibility criteria. Family history alone does not automatically qualify someone for screening.
Collect your family cancer history. Record which relatives had cancer, the type of cancer, and their age at diagnosis. Include cancers other than lung cancer, since the broader family pattern may provide important context.
Consider genetic counseling when the broader family history suggests inherited cancer risk. This may include multiple relatives with cancer, cancers diagnosed at unusually young ages, a known inherited cancer-related gene change, or a pattern of cancers associated with a hereditary cancer syndrome. A genetic counselor can help determine whether genetic testing may be appropriate.
No. A parent’s diagnosis does not mean you will develop lung cancer. It may be useful, however, to discuss your family history and your own exposure history with a physician—especially if the diagnosis occurred at a young age, your parent never smoked, or there are other cancers in the family.
An inherited gene change can come from either parent. But lung cancer itself is not commonly caused by one inherited gene change. If a hereditary syndrome is suspected, genetic counseling can help determine whether testing is appropriate.
A lung cancer diagnosis in someone who never smoked does not necessarily indicate an inherited cause. If it occurs alongside a strong or unusual family history of cancer, a clinician can help determine whether genetic counseling may be appropriate.
Family history alone does not automatically make someone eligible for low-dose CT screening under current USPSTF recommendations. Your clinician can help assess your complete risk profile and whether you meet screening criteria.
No. Genetic testing and lung cancer screening serve different purposes. Genetic testing may clarify inherited cancer risk in selected families. Low-dose CT screening is an imaging test used for people who meet specific risk-based eligibility criteria. One does not replace the other.
Lung cancer is not usually hereditary, but family history can still matter. If your family has a pattern of early-onset cancers, multiple related cancers, or lung cancer in people with little or no smoking history, a more complete risk conversation may be worthwhile.
When a person's broader family history suggests that an inherited cancer syndrome may be present, genetic counseling can help determine whether hereditary cancer-risk testing is appropriate.